Investigational drug stops toxic proteins tied to neurodegenerative diseases
Tuesday, September 8, 2020 - 13:11
in Health & Medicine
An investigational drug that targets an instigator of the TDP-43 protein, a well-known hallmark of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), may reduce the protein's buildup and neurological decline associated with these disorders, suggests a pre-clinical study.